COMPLETE ANDROGEN BLOCKADE SAFELY ALLOWS FOR DELAY OF CYTOTOXIC CHEMOTHERAPY IN CASTRATION REFRACTORY PROSTATE CANCER

Complete androgen blockade safely allows for delay of cytotoxic chemotherapy in castration refractory prostate cancer

PURPOSE: Complete androgen blockade (CAB) does not prolong overall survival (OS) in patients with castration refractory prostate cancer (CRPC).Although there is variable clinical benefit with second-line hormone manipulation, we do not know which patients might benefit the most.OBJECTIVES: To identify clinical predictors of benefit of complete andr

read more